NEW YORK (GenomeWeb News) — Metabolon announced Friday that it has raised $15 million through a private placement of preferred stock.

Investors in the Series E round included Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners, as well as Japanese firm Sumitomo. The round was led by Camden Partners.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.